The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. TherapeuticsMD Inc shares valued at $326 were purchased by Thompson Tommy G on Apr 14 ’25. At $1.00 per share, Thompson Tommy G acquired 325 shares. The insider’s holdings grew to 14,779 shares worth approximately $15961.320000000002 following the completion of this transaction.
Also, Walker Marlan D purchased 490 shares, netting a total of over 489 in proceeds. Following the buying of shares at $1.00 each, the insider now holds 73,639 shares.
Before that, Walker Marlan D had added 1,167 shares to its account. In a trade valued at $1,000, the Chief Executive Officer bought TherapeuticsMD Inc shares for $0.86 each. Upon closing the transaction, the insider’s holdings increased to 1,167 shares, worth approximately $79000.92.
As published in a research note from Jefferies on August 07, 2020, TherapeuticsMD Inc [TXMD] has been rated down from a Hold to an Underperform. Analysts at JP Morgan downgraded the stock from ‘”an Overweight”‘ to ‘”a Neutral”‘ outlook in a report released in mid May. As of December 02, 2019, Guggenheim has initiated its “Buy” rating for TXMD. Earlier on October 17, 2019, H.C. Wainwright initiated its rating. Their recommendation was “a Buy” for TXMD stock.
Analyzing TXMD Stock Performance
On last trading session,, TherapeuticsMD Inc [NASDAQ: TXMD] plunged -3.57% to $1.08. The stock’s lowest price that day was $1.08, but it reached a high of $1.22 in the same session. During the last five days, there has been a drop of approximately -10.00%. Over the course of the year, TherapeuticsMD Inc shares have jumped approximately 25.58%. Shares of the company reached a 52-week high of $2.4400 on 01/03/25 and a 52-week low of $0.7200 on 03/14/25.
Support And Resistance Levels for TherapeuticsMD Inc (TXMD)
According to the 24-hour chart, there is a support level at 1.0333, which, if violated, would cause prices to drop to 0.9867. In the upper region, resistance lies at 1.1733. The next price resistance is at 1.2667. RSI (Relative Strength Index) is 37.04 on the 14-day chart, showing neutral technical sentiment.
Is TherapeuticsMD Inc subject to short interest?
Stocks of TherapeuticsMD Inc saw a sharp steep in short interest on 2025-05-30 dropping by 34211.0 shares to 83865.0. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 0.12 million shares. A decline of -40.79% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.16 of the overall float, the days-to-cover ratio (short ratio) decline to 2.16.
